Explore the full agenda for the 9th Annual D&I Conference, now available online.
Wednesday, December 14
9:00 a.m. - 9:20 a.m.
Opening Plenary Session: Welcome and Conference Overview
- David Chambers, Deputy Director, Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute
- Lisa Simpson, President and CEO, AcademyHealth
9:20 a.m. – 10:15 a.m.
Keynote Address: The Innovation Conundrum
Roy Rosin, Chief Innovation Officer at Penn Medicine
10:15 a.m. – 10:45 a.m.
10:45 a.m. – 12:00 p.m.
Plenary Session: Balancing Adaptation and Fidelity: Exploring the Continuum Frequently, efforts to implement evidence-based interventions have had to address the challenges around whether to remain faithful to the original design of an intervention (fidelity) or whether to adapt to local populations, contexts, or delivery models. In addition, there is often a need for adaptation of systems and organizations in which clinical interventions are being implemented, as well as for adaptation of implementation strategies. Recognizing that decisions may go beyond a simple, either/or decision to consider when, how and why adaptations are necessary. This lunch discussion forum will provide an opportunity for participants to address the challenges of and strategies for studying adaptation without sacrificing meaningful fidelity.
Moderator: Greg Aarons, University of California, San Diego
- Don Goldmann, Chief Medical and Scientific Officer, Institute for Healthcare Improvement
- Amy Kilbourne, Director of the Quality Enhancement Research Initiative national program, VA
- Susan Michie, Professor of Health Psychology at University College London
- Lisa Saldana, Oregon Social Learning Institute
12:15 p.m.–1:45 p.m.
Lunch Discussion Forums
2:00 p.m.–.3:30 p.m.
Concurrent Sessions and Poster Slam
3:30 p.m.– 4:00 p.m.
4:00 p.m.–5:30 p.m.
5:30 pm–7:00 p.m.
Thursday, December 15
8:00 a.m.–9:30 a.m.
Plenary Session: Planning for the Long Term: Considering Sustainment and De-Implementation of Interventions
Challenged with the limits of short-term goals and limitations in funding, dissemination and implementation researchers often are focusing on the initial stages of adoption and implementation. This panel will explore how the field can think about long term outcomes of the efforts to disseminate and implement evidence and evidence-based interventions, specifically concentrating on decisions regarding sustainment or de-implementation of interventions.
Moderator: David Chambers, Deputy Director, Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute
- Robert Kaplan, Univerity of California, Los Angeles
- Catherine Sarkisian, University of California, Los Angeles
- Sharon Straus, Professor in the Department of Medicine at the University of Toronto
- Shannon Wiltsey Stirman, Clinical Psychologist, National Center for PTSD, VA Palo Alto Healthcare System and Stanford University
9:30 a.m. – 9:45 a.m.
9:45 a.m. – 11:15 a.m.
11:15 a.m. – 12:45 p.m.
Poster Session II
12:45 pm–2:15 pm
On Your Own
2:15 p.m. – 3:45 p.m.
3:45 p.m.– 4:00 p.m.
4:00 p.m. - 5:15 p.m.
Closing Plenary: Novel Directions in Dissemination Research
Within the funded research, far greater emphasis seems to be placed on implementation of evidence-based practices than on dissemination processes to get evidence and evidence-based interventions spread to target audiences. With great advances in communications technology and new sources of data, this panel will explore future directions for dissemination researchers.
Moderator: Gila Neta, Program Director, Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute
- Hilda Bastian, National Institutes of Health
- Gary Bennett, Duke University
- Matt Kreuter, Kahn Family Professor of Public Health and Associate Dean for Public Health at The Brown School at Washington University in St. Louis
- Randy Schwartz, Senior Vice President of Health Systems, American Cancer Society